GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techlead NPN PCL (BKK:EE) » Definitions » Debt-to-EBITDA

Techlead NPN PCL (BKK:EE) Debt-to-EBITDA : 0.02 (As of Dec. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Techlead NPN PCL Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Techlead NPN PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ฿11.85 Mil. Techlead NPN PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ฿0.00 Mil. Techlead NPN PCL's annualized EBITDA for the quarter that ended in Dec. 2024 was ฿539.43 Mil. Techlead NPN PCL's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 0.02.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Techlead NPN PCL's Debt-to-EBITDA or its related term are showing as below:

BKK:EE' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.32   Med: -0.01   Max: 0.47
Current: -0.32

During the past 13 years, the highest Debt-to-EBITDA Ratio of Techlead NPN PCL was 0.47. The lowest was -0.32. And the median was -0.01.

BKK:EE's Debt-to-EBITDA is ranked worse than
100% of 674 companies
in the Drug Manufacturers industry
Industry Median: 1.62 vs BKK:EE: -0.32

Techlead NPN PCL Debt-to-EBITDA Historical Data

The historical data trend for Techlead NPN PCL's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techlead NPN PCL Debt-to-EBITDA Chart

Techlead NPN PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.01 -0.01 -0.01 -0.32

Techlead NPN PCL Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.07 -0.03 -0.04 0.02

Competitive Comparison of Techlead NPN PCL's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Techlead NPN PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Techlead NPN PCL's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Techlead NPN PCL's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Techlead NPN PCL's Debt-to-EBITDA falls into.


;
;

Techlead NPN PCL Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Techlead NPN PCL's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(11.85 + 0) / -36.534
=-0.32

Techlead NPN PCL's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(11.85 + 0) / 539.428
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


Techlead NPN PCL  (BKK:EE) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Techlead NPN PCL Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Techlead NPN PCL's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Techlead NPN PCL Business Description

Traded in Other Exchanges
Address
Ngamwongwan Road, 5th Floor, 50 Chulabhorn Science Research Center Building, Ladyao Subdistrict, Chatuchak District, Bangkok, THA, 10900
Techlead NPN PCL is a Thailand-based holding company that operates an agriculture business. The Company, through its subsidiary, Cannabiz Way Company Limited, operates the business of planting, extracting, processing, distributing, importing, exporting, and conducting all business related to hemp/marijuana raw materials. The Company, through its subsidiary, CBD Bioscience Company Limited, is engaged in the cultivation of hemp in greenhouses using the Evaporative Cooling System (EVAP), a closed farming system, which maintains the temperature at the appropriate level and works well in preventing epidemic disease in Nong Yuang, Wiang Nong Long, Lamphun.